Description

Book Synopsis

Section 1: Fluid and Imaging Markers of Pathologies associated with Alzheimer Disease or other Related Dementias.- Chapter 1: Fluid and Imaging Markers of Amyloid Pathology.- Chapter 2: Fluid Markers of Tau Pathology.- Chapter 3: Fluid and Imaging Markers of Synuclein Pathology.- Chapter 4: Fluid and Imaging Markers of Synaptic Injury.- Chapter 5: Fluid Markers of Neuronal and Axonal Injury.- Chapter 6: Fluid and Imaging Markers of Glial Reactivity.- Chapter 7: Fluid and Imaging Markers of Vascular Disease.- Section 2: Fluid and Imaging Markers of Neurodegenerative Disorders.- Chapter 8: Fluid and Imaging Markers of Alzheimer Disease.- Chapter 9: Fluid and Imaging Markers of Frontotemporal Lobar Degeneration.- Chapter 10: Fluid and Imaging Markers of Lewy body dementias.- Chapter 11: Fluid and Imaging Markers of Huntington's Disease.- Section 3: Single and Integrated Omics Studies in Biomarker Discovery.- Chapter 12: Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease.- Chapter 13: Genomics and Transcriptomics of Alzheimer Disease.- Section 4: Biomarkers in Clinical and Translational Alzheimer Disease Research.- Chapter 14: Biomarkers in Clinical Trials of Alzheimer Disease: An Overview.- Chapter 15: Biomarkers As Outcome Measures in Clinical Trials of Alzheimer Disease.- Chapter 16: Impact of Pre-analytical Factors on Fluid Biomarker Measurements in Alzheimer Disease.- Chapter 17: Mild Behavioral Impairment and Alzheimer's Disease Biomarker Sample Enrichment for Clinical Trial Screening and Recruitment.- Section 5: Future Directions in Biomarker Research.- Chapter 18: Extracellular Vesicles as Biomarkers in Alzheimer Disease and Related Dementias.- Chapter 19: Sex Differences in Alzheimer Disease-Related Biomarkers and Dementia Risk.- Chapter 20: Imaging Markers of Amyloid and Tau.- Chapter 21: Novel Markers of Brain Endothelial Injury.- Epilogue: Expert Commentary on Future Directions or Epilogue: Sex/racial differences, standardization, and TDP-43.

Biomarkers of Neurodegenerative Disorders

    Product form

    £189.99

    Includes FREE delivery

    RRP £199.99 – you save £10.00 (5%)

    Order before 4pm today for delivery by Mon 22 Jun 2026.

    A Hardback by Rawan Tarawneh

    15 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Biomarkers of Neurodegenerative Disorders by Rawan Tarawneh

      Publisher: Springer
      Publication Date: 4/5/2025
      ISBN13: 9783031808487, 978-3031808487
      ISBN10: 3031808487
      Also in:
      Neurosciences

      Description

      Book Synopsis

      Section 1: Fluid and Imaging Markers of Pathologies associated with Alzheimer Disease or other Related Dementias.- Chapter 1: Fluid and Imaging Markers of Amyloid Pathology.- Chapter 2: Fluid Markers of Tau Pathology.- Chapter 3: Fluid and Imaging Markers of Synuclein Pathology.- Chapter 4: Fluid and Imaging Markers of Synaptic Injury.- Chapter 5: Fluid Markers of Neuronal and Axonal Injury.- Chapter 6: Fluid and Imaging Markers of Glial Reactivity.- Chapter 7: Fluid and Imaging Markers of Vascular Disease.- Section 2: Fluid and Imaging Markers of Neurodegenerative Disorders.- Chapter 8: Fluid and Imaging Markers of Alzheimer Disease.- Chapter 9: Fluid and Imaging Markers of Frontotemporal Lobar Degeneration.- Chapter 10: Fluid and Imaging Markers of Lewy body dementias.- Chapter 11: Fluid and Imaging Markers of Huntington's Disease.- Section 3: Single and Integrated Omics Studies in Biomarker Discovery.- Chapter 12: Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease.- Chapter 13: Genomics and Transcriptomics of Alzheimer Disease.- Section 4: Biomarkers in Clinical and Translational Alzheimer Disease Research.- Chapter 14: Biomarkers in Clinical Trials of Alzheimer Disease: An Overview.- Chapter 15: Biomarkers As Outcome Measures in Clinical Trials of Alzheimer Disease.- Chapter 16: Impact of Pre-analytical Factors on Fluid Biomarker Measurements in Alzheimer Disease.- Chapter 17: Mild Behavioral Impairment and Alzheimer's Disease Biomarker Sample Enrichment for Clinical Trial Screening and Recruitment.- Section 5: Future Directions in Biomarker Research.- Chapter 18: Extracellular Vesicles as Biomarkers in Alzheimer Disease and Related Dementias.- Chapter 19: Sex Differences in Alzheimer Disease-Related Biomarkers and Dementia Risk.- Chapter 20: Imaging Markers of Amyloid and Tau.- Chapter 21: Novel Markers of Brain Endothelial Injury.- Epilogue: Expert Commentary on Future Directions or Epilogue: Sex/racial differences, standardization, and TDP-43.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account